Flucelvax Injection, Suspension
Substitutes & Crosswalk NDC 87063-299

The similar products listed below help you identify alternative medications based on regulatory status, active ingredients, and administration routes. Identify therapeutic equivalents and alternative medications for Flucelvax (NDC 87063-299). This cross-referenced list provides clinically relevant matches based on the following criteria:

• Generic Bioequivalence: Products sharing the generic name: Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/tasmania/787/2025 Cvr-388 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/arizona/21/2025 Antigen (mdck Cell Derived, Propiolactone Inactivated).
• Administration Consistency: Same Route (intramuscular) and Dosage Form (injection, suspension).
• Brand Alternatives: Different proprietary names for the same chemical entity.

This clinical crossover tool is designed for healthcare professionals, pharmacists, and patients to safely compare substitute products and manage medication availability.